Coherus Oncology (CHRS) Total Debt Growth (1y) (2015 - 2026)
Coherus Oncology (CHRS) Total Debt Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Coherus Oncology | 194.37 Mn | 27.32 Mn | 8.50 Mn | 1.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00% |
| Dec 31, 2025 | 0.96% |
| Sep 30, 2025 | 0.93% |
| Jun 30, 2025 | 0.89% |
| Mar 31, 2025 | -49.23% |
| Dec 31, 2024 | -85.31% |
| Sep 30, 2024 | -85.37% |
| Jun 30, 2024 | -85.14% |
| Mar 31, 2024 | -70.51% |
| Dec 31, 2023 | 1.75% |
| Sep 30, 2023 | 2.04% |
| Jun 30, 2023 | 25.47% |
| Mar 31, 2023 | 25.46% |
| Dec 31, 2022 | 225.09% |
| Sep 30, 2022 | 225.99% |
| Jun 30, 2022 | 161.53% |
| Mar 31, 2022 | 162.19% |
| Dec 31, 2021 | 1.39% |
| Sep 30, 2021 | 183.77% |
| Jun 30, 2021 | 1.21% |